Goldman Sachs Group »

Aytu Biopharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 14k 2.84

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Aytu Biopharma

Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
Goldman Sachs Group
Jpmorgan Chase & Co
Royal Bank of Canada
Advisor Group Holdings
UBS Group
Wells Fargo & Company
West Financial Advisors
CarsonAllaria Wealth Management
Citigroup
TSFG

View all funds holding Aytu Biopharma